v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 885 $ 268
Restricted cash and cash equivalents 7,303 6,708
Premiums receivable 230 766
Deferred policy acquisition costs 41 102
Operating lease right-of-use assets 89 43
Prepayment and other assets 174 150
Property and equipment, net 15 16
Total assets 8,737 8,053
Liabilities:    
Reserve for losses and loss adjustment expenses 91 91
Notes payable to noteholders 118 118
Unearned premiums reserve 370 926
Losses payable 73 73
Loan payable 1,000
Operating lease liabilities 89 43
Accounts payable and other liabilities 381 309
Total liabilities 2,122 1,560
Mezzanine Equity    
Due to EpsilonCat Re / DeltaCat Re / EtaCat Re / ZetaCat Re Tokenholders 520 518
Shareholders’ equity:    
Ordinary share capital, (par value $0.001, 500,000,000 shares authorized; 7,801,374 and 7,664,122 shares issued and outstanding) 6 6
Additional paid-in capital 38,129 38,047
Accumulated Deficit (32,115) (32,137)
Total Oxbridge shareholders’ equity 6,020 5,916
Non-controlling interests 75 59
Total shareholders’ equity 6,095 5,975
Total liabilities, mezzanine and shareholders’ equity $ 8,737 $ 8,053